Sector: Agricultural Food & other Products - Fast Moving Consumer Goods
BSE Code: 519353
NSE Symbol: BANSTEA
ISIN: INE856E01019
📅 NOVYRA PHARMACHEM (formerly Bansisons Tea) Reschedules Board Meeting - NOVYRA PHARMACHEM LIMITED (formerly Bansisons Tea Industries Limited) has postponed its Board Meeting. - The meeting was originally scheduled for April 18, 2026 and is now rescheduled to April 25, 2026. - The purpose is to c…
📅 Bansisons Tea Industries Ltd Board Meeting Scheduled for April 18, 2026 • Board meeting scheduled for Saturday, April 18, 2026 • Agenda includes approval of audited financial results for quarter and year ended March 31, 2026 • Trading window for company securities closed from April 1, 2026 unti…
📊 Independent Directors Review Board Performance at Novyra Pharmachem • Independent Directors meeting held on March 20, 2026 • Reviewed performance of non-independent directors and full board • Assessed Chairperson's performance with input from executive/non-executive directors • Evaluated qualit…
📅 Independent Directors Meeting Scheduled for Novyra Pharmachem Ltd • Independent Directors meeting scheduled for March 20, 2026 • Meeting location: Company's registered office in Surat, Gujarat, India • Agenda includes review of Non-Independent Directors' performance • Board performance assessme…
📈 Novyra Pharmachems Appoints New Executive Director with 25+ Years Experience • Anilkumar Mohanbhai Amreliya appointed as Additional Director (Executive Director) effective February 6, 2026 • Brings over 25 years of experience in sales and marketing • Currently holds directorships in Vaidehi Hea…
📊 Novyra Pharmachem Q3 FY2026 Results: Net Loss of ₹1.15 Lakhs • Net loss of ₹1.15 lakhs for Q3 ended Dec 31, 2025 • No revenue from operations in Q3 • Other income of ₹2.22 lakhs in Q3 • Nine-month net loss of ₹1.82 lakhs • Nine-month other income of ₹6.31 lakhs • Employee benefit expenses: ₹0.3…
📅 Bansisons Tea Industries Reschedules Board Meeting to Review Q3 FY2026 Results - Board meeting postponed from January 22 to January 26, 2026. - Agenda: Approval of Unaudited Financial Results for quarter ended December 31, 2025.
Bansisons Tea Industries Ltd Shares Compliance Update for Q4 2025 📄 - Submitted SEBI Regulation 74(5) compliance certificate for the quarter ended December 31, 2025. - Verification and cancellation of mutilated security certificates completed by depository participant. - Register of members updat…
📅 Bansisons Tea Industries Board Meeting: Key Updates on Q2 Financials - Board meeting scheduled for 22nd January 2026 at the company’s registered office in Surat, Gujarat. - Agenda includes approval of unaudited financial results for Q2 ending 31st December 2025. - Auditor’s Limited Review Repor…
Bansisons Tea Industries Ltd. Shareholders Approve Major Changes 🚀 - Postal ballot conducted via remote e-voting from Nov 29 to Dec 29, 2025. - All 3 resolutions passed with 100% votes in favor. - Resolution 1: Change in Object Clause of Memorandum of Association. - Resolution 2: Company name cha…
🚀 Bansisons Tea Industries Shifts Base to Gujarat – New CIN Issued - Bansisons Tea Industries Limited has moved its registered office from West Bengal to Gujarat, effective December 24, 2025. - The relocation has resulted in a new Corporate Identification Number (CIN) for the company: L15520GJ198…
Bansisons Tea Clarifies Audit Submission & Posts FY21 Results 📊 - Statutory Auditors issued an unmodified audit report for FY 2020-21 (no qualifications/adverse remarks). - FY21 profit after tax: ₹788,652 (vs. loss of ₹178,712 in FY20). - Total revenue from operations: ₹1,500,000 (flat YoY). - To…
Bansisons Tea Clarifies FY 2021-22 Audit Report Omission 📊 - Submitted clarification for non-submission of Audit Report & Declaration for FY 2021-22. - Original standalone audited results filed on 04 Aug 2022, but omitted required documents. - Statutory auditors (R.K. Bihani & Associates) issued …
Bansisons Tea Industries Ltd: Financial Highlights & Key Updates 📊 - Paid-up capital remained steady at Rs. 61,975,500 for both 2021 and 2020. - Reserves & surplus deficit improved from Rs. 2,049,745 (2020) to Rs. 1,261,093 (2021). - Current liabilities rose from Rs. 948,181 (2020) to Rs. 1,483,1…
🚀 Bansisons Tea Industries Shifts Registered Office to Gujarat – Key Details Inside - Bansisons Tea Industries Limited has secured approval to relocate its Registered Office from West Bengal to Gujarat. - The approval was granted by the Regional Director (Eastern Region), Kolkata on November 28, …
🚀 Bansisons Tea Industries Shifts Gears: Expanding into Pharma & Chemicals - Shareholder approval sought to expand into pharmaceutical, chemical, and related sectors via a change in the Main Object Clause. - Company name change proposed from 'Bansisons Tea Industries Limited' to 'Novyra Pharmache…
📢 Key Leadership Change at Bansisons Tea Industries: Independent Director Resigns - Mrs. Mamy Ghosh (DIN: 06532484) resigns as Independent Director, effective November 19, 2025. - Resignation reason: Pre-occupation. - No other material reasons for resignation beyond those stated. - Mrs. Ghosh hol…
Bansisons Tea Industries Ltd Announces Key Updates: Name Change, Land Sale & Director Resignation 🔄 - Approved change of company name from 'Bansisons Tea Industries Limited' to 'Quantum Care Pharmachem Limited' or 'Novyra Pharmachem Limited' (pending MCA approval and shareholder consent). - Appro…
Bansisons Tea Industries Ltd Announces Key Board Meeting Decisions 🍃📋 - Board meeting scheduled for November 19, 2025, at the company's registered office. - Agenda includes approval to change the Object Clause of the Memorandum of Association (subject to shareholder approval). - Proposal to upda…
Bansisons Tea Industries Ltd Announces Key Board Meeting Decisions 🏢📅 - Board meeting scheduled for 19th November, 2025 at the company's registered office. - Agenda includes approval to change the Object Clause of the Memorandum of Association, subject to shareholder approval. - Approval for the…